TrialSignal
Clinical trial intelligence report
Inhaled Nitric Oxide in Neonates With Elevated A-aDO2 Gradients Not Requiring Mechanical Ventilation
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT00732537
Status
COMPLETED
Phase
PHASE4
Sponsor
University of Alabama at Birmingham
Executive brief
Investment-Ready Snapshot
Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near-term infants who have poor oxygenation but who are not yet mechanically ventilated.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00732537
Indication
Respiratory Failure
Modality
small molecule
Target
inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy
Intervention
inhaled Nitric Oxide, Oxygen (>90% by hood) - standard therapy
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.